Healthcare -
Biotechnology - NASDAQ - US
$ 29.55
1.41 %
$ 4.6 B
Market Cap
-295.5
P/E
TGTX - STOCK-BASED COMPENSATION
Stock-based Compensation TGTX - TG Therapeutics, Inc.
37.9 M
LAST VALUE
-21.32%
2 YEAR CAGR
24.10%
5 YEAR CAGR
21.98%
10 YEAR CAGR